Cupid 4:1 Bonus Share Allotment Completed 10 March 2026; Shares Rise 0.98%

Mumbai, March 10: Cupid Ltd informed exchanges on Tuesday that its board has approved and completed the allotment of 107,57,28,560 fully paid-up bonus equity shares of face value ₹1 each in the proportion of 4:1, according to a regulatory disclosure filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The corporate action grants four new fully paid-up equity shares for every one existing equity share of ₹1 held by eligible shareholders. The entitlement was determined based on the record date of March 9, 2026, as stated in the company’s exchange filing.

Following the allotment, the company’s paid-up equity share capital expanded significantly. The number of outstanding shares increased from 26,89,32,140 equity shares to 134,46,60,700 equity shares after the bonus issue. The newly issued bonus shares will rank pari-passu with existing equity shares in all respects.

The disclosure was signed by Saurabh V. Karmase, Company Secretary and Compliance Officer, through a digitally authenticated filing submitted to both BSE and the National Stock Exchange.

Share Price Movement On March 10, 2026

Cupid Ltd shares ended the trading session on March 10, 2026 at ₹92.50, rising 0.98% from the previous close of ₹91.60, according to exchange market data.

During the session the stock traded between an intraday high of ₹95.85 and a low of ₹91.10. The price movement occurred alongside the regulatory update confirming the completion of the bonus share allotment.

At the close, the company’s market capitalisation stood near ₹12,440 crore with the stock trading at a price-to-earnings ratio of approximately 30.03 based on exchange statistics.

Company Background

Cupid Ltd operates in the sexual wellness and medical diagnostics segment. The company manufactures male and female condoms, water-based lubricants and in vitro diagnostic kits. Its products are supplied across domestic and international markets, including government procurement programmes and institutional healthcare buyers.

The company has historically focused on export-led revenue streams and participates in global public health supply chains that procure contraceptive and related healthcare products.

Conclusion

The completion of the 4:1 bonus share allotment marks a capital restructuring step that substantially increases the company’s outstanding equity base. Such bonus issuances typically aim to enhance liquidity in the secondary market by increasing the number of tradable shares while keeping overall shareholder value proportionally unchanged.

The corporate action has now been formally recorded with the exchanges following the allotment approved on March 10, 2026.

Source:

• https://www.nseindia.com/get-quote/equity/CUPID/Cupid-Limited
• https://nsearchives.nseindia.com/corporate/CUPID_10032026132357_Intimation_of_Allotment_of_Bonus_Shares.pdf